Skip to main content
SpringerLink
Log in
Book cover

Nanomaterial-Based Drug Delivery Carriers for Cancer Therapy pp 7–13Cite as

Clinical Anticancer Drugs for Cancer Treatment

  • Chapter
  • First Online:

Part of the book series: SpringerBriefs in Applied Sciences and Technology ((BRIEFSNANO))

Abstract

Chemotherapy is the most widely used therapeutic strategy in the cancer treatment. The high incidence of cancer has led to a lot of immunotherapeutic and chemotherapeutic drugs to be developed and approved by U.S. Food and Drug Administration (FDA). This chapter presents different kinds of antineoplastic agents that have been approved or under development.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Dean M, Fojo T, Bates S (2005) Tumour stem cells and drug resistance. Nat Rev Cancer 5:275–284

    Article  Google Scholar 

  • Gao Y, Xie J, Chen H, Gu S, Zhao R, Shao J, Lee J (2014) Nanotechnology-based intelligent drug design for cancer metastasis treatment. Biotechnol Adv 32:761–777

    Article  Google Scholar 

  • Gottesman MM (2002) Mechanisms of cancer drug resistance. Annu Rev Med 53:615–627

    Article  Google Scholar 

  • Mignani SM, Bryszewska M, Klajnert-Maculewicz B, Zablocka M, Majoral JP (2015) Advances in combination therapies based on nanoparticles for efficacious cancer treatment: an analytic report. Biomacromolecules 16:1–27

    Article  Google Scholar 

  • Spencer DS, Puranik AS, Peppas NA (2015) Intelligent nanoparticles for advanced drug delivery in cancer treatment. Curr Opin Chem Eng 7:84–92

    Article  Google Scholar 

  • Szakacs G, Paterson JK, Ludwig JA, Booth-Genthe C, Gottesman MM (2006) Targeting multidrug resistance in cancer. Nat Rev Drug Discovery 5:219–234

    Article  Google Scholar 

  • Szakacs G, Jakab K, Antal F, Sarkadi B (2008) Diagnostics of multidrug resistance in cancer. Pathol Oncol Res 4:251–257

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Chemistry and Biological Chemistry, School of Physical and Mathematical Sciences, Nanyang Technological University, Singapore, Singapore

    Tao Feng & Yanli Zhao

Authors
  1. Tao Feng
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yanli Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yanli Zhao .

Rights and permissions

Reprints and permissions

Copyright information

© 2017 The Author(s)

About this chapter

Cite this chapter

Feng, T., Zhao, Y. (2017). Clinical Anticancer Drugs for Cancer Treatment. In: Nanomaterial-Based Drug Delivery Carriers for Cancer Therapy. SpringerBriefs in Applied Sciences and Technology(). Springer, Singapore. https://doi.org/10.1007/978-981-10-3299-8_2

Download citation

  • DOI: https://doi.org/10.1007/978-981-10-3299-8_2

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-10-3297-4

  • Online ISBN: 978-981-10-3299-8

  • eBook Packages: EngineeringEngineering (R0)

Publish with us

Policies and ethics

Search

Navigation